Tang Capital Management’s Aligos Therapeutics ALGS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Hold |
141,131
| – | – | 0.05% | 152 |
|
|
2025
Q1 | $1.16M | Buy |
+141,131
| New | +$1.16M | 0.06% | 145 |
|
|
2024
Q3 | – | Sell |
-66,000
| Closed | -$578K | – | 156 |
|
|
2024
Q2 | $578K | Hold |
66,000
| – | – | 0.06% | 104 |
|
|
2024
Q1 | $1.62M | Sell |
66,000
-21,594
| -25% | -$529K | 0.17% | 80 |
|
|
2023
Q4 | $1.45M | Sell |
87,594
-45,568
| -34% | -$756K | 0.13% | 99 |
|
|
2023
Q3 | $2.49M | Hold |
133,162
| – | – | 0.35% | 65 |
|
|
2023
Q2 | $3.23M | Sell |
133,162
-3,830
| -3% | -$93K | 0.48% | 58 |
|
|
2023
Q1 | $2.99M | Buy |
136,992
+24,336
| +22% | +$532K | 0.45% | 53 |
|
|
2022
Q4 | $2.68M | Buy |
112,656
+45,689
| +68% | +$1.09M | 0.39% | 56 |
|
|
2022
Q3 | $1.84M | Buy |
66,967
+5,059
| +8% | +$139K | 0.23% | 72 |
|
|
2022
Q2 | $1.87M | Buy |
+61,908
| New | +$1.87M | 0.28% | 52 |
|